ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals Inc (SNDX)

21,31
1,50
(7,57%)
Fermé 27 Juin 10:00PM
21,0451
-0,2649
(-1,24%)
Après les heures de négociation: 11:45PM

Syndax Pharmaceuticals Inc (SNDX) Opérations d'Initiés

-
Filtrer par:
Date Nom du détenteur Actions transigées Fourchette de valeur ($) Type d'opération Fourchette de prix ($) Actions en fin de déclaration % de variation
2026-06-01Mr. Michael A. MetzgerCEO & Director-6,85k130,02kVente18,9963,16k-9,78%
2026-06-01Mr. Keith Alan GoldanCFO, Treasurer & Principal Accounting Officer-1,18k22,35kVente18,9927,90k-4,05%
2026-02-09Mr. Keith Alan GoldanCFO, Treasurer & Principal Accounting Officer-3,41k71,71kVente21,0329,08k-10,50%
2026-02-09Mr. Michael A. MetzgerCEO & Director-17,16k360,82kVente21,0370,01k-19,69%
2026-02-06Mr. Michael A. MetzgerCEO & Director-7,41k152,84kVente20,6287,17k-7,84%
2026-02-06Mr. Keith Alan GoldanCFO, Treasurer & Principal Accounting Officer-2,08k42,93kVente20,6220,82k-9,09%
2025-12-01Mr. Keith Alan GoldanCFO, Treasurer & Principal Accounting Officer-1,22k0,00Other Disposition-15,52k-7,31%
2025-09-08Mr. Michael A. MetzgerCEO & Director-157,31k867,38kDerivative Exercise and Sale10,90 - 16,4138,66k-
2025-08-14Mr. Dennis G. PodlesakIndependent Chairman-57,60k460,38kDerivative Exercise and Sale7,20 - 15,8414,43k-
2025-07-16Mr. Michael A. MetzgerCEO & Director-7,53k69,95kVente9,2938,66k-16,31%
2025-07-16Mr. Keith Alan GoldanCFO, Treasurer & Principal Accounting Officer-1,30k12,03kVente9,2915,52k-7,71%